Evolution of CCR4highCD4+ Subpopulations in Renal Graft Blood After Steroid Withdrawal: A Prospective, Randomized, Controlled Study in Parallel Groups. Preliminary Results.
1Nephrology, Regional University Hospital and Malaga University, IBIMA, RD16/0009/0006, Malaga, Spain
2Immunology, Regional University Hospital of Malaga, Malaga, Spain
Meeting: 2017 American Transplant Congress
Abstract number: D116
Keywords: CD4, Immunosuppression, Kidney transplantation
Session Information
Session Name: Poster Session D: Kidney Immunosuppression: Novel Regimens and Drug Minimization
Session Type: Poster Session
Date: Tuesday, May 2, 2017
Session Time: 6:00pm-7:00pm
Presentation Time: 6:00pm-7:00pm
Location: Hall D1
Introduction:Steroids are a mainstay of immunosuppression after kidney transplant (KT). The infiltration into the graft of active T cells following KT depends on the expression of chemokines and their interaction with their T-cell receptors. However, the natural history of there expression in patients who undergo steroid withdrawal after KT is unknown.
Material and methods:In a clinical trial (NCT02284464) 176 KT patients with low immunological risk were recruited to randomly receive either conventional therapy: steroids, TAC and MMF (A) vs steroid withdrawal at post-KT month 3 (B). We compared the evolution of CCR4highCD4+ and CXCR3highCD4+ subpopulations in graft blood (GB) drawn by fine needle aspiration puncture determined by flow cytometry in patients after steroid withdrawal at post-KT month 3 vs patients who continue with conventional therapy. Measurements were made at 3 (baseline) and 6 months post-KT in GB and peripheral blood (PB).
Results:So far, 68 patients have been randomized, with no significant baseline clinical or demographic differences. The first analysis (month 3) in the patients who had completed 6 months follow-up (A: n=13; B: n=15) showed a significant increase in the CCR4highCD4 subpopulations in GB vs PB in both groups. However, at month 6 a significant increase in GB vs PB was only seen in Group A. There were no significant differences in the CXCR3highCD4+ subpopulation at month 3 or 6 between GB and PB.
Group A | Group B | |||||
PB | GB | P | PB | GB | P | |
CCR4highCD4+(%) | ||||||
3 m | 0.40±0.34 | 2.28±2.46 | .001 | 0.45±0.64 | 2.09±3.84 | .003 |
6 m | 0.42±0.57 | 2.97±5.35 | .023 | 0.71±0.81 | 1.27±1.43 | .117 |
CXCR3highCD4+(%) | ||||||
3 m | 0.78±1.54 | 0.82±1.30 | .950 | 0.72±1.34 | 0.50±0.92 | .567 |
6 m | 0.99±1.73 | 1.63±4.64 | .423 | 2.82±4.70 | 1.05±1.55 | .063 |
Conclusion:This results could suggest a possible effect of steroids, favoring recruitment of CCR4highCD4+ cells into the renal graft.
CITATION INFORMATION: Alonso-Titos J, Ruiz-Esteban P, Palma E, Caballero A, Sola E, Cabello M, Vazquez T, Duarte A, Jironda C, Hernandez D. Evolution of CCR4highCD4+ Subpopulations in Renal Graft Blood After Steroid Withdrawal: A Prospective, Randomized, Controlled Study in Parallel Groups. Preliminary Results. Am J Transplant. 2017;17 (suppl 3).
To cite this abstract in AMA style:
Alonso-Titos J, Ruiz-Esteban P, Palma E, Caballero A, Sola E, Cabello M, Vazquez T, Duarte A, Jironda C, Hernandez D. Evolution of CCR4highCD4+ Subpopulations in Renal Graft Blood After Steroid Withdrawal: A Prospective, Randomized, Controlled Study in Parallel Groups. Preliminary Results. [abstract]. Am J Transplant. 2017; 17 (suppl 3). https://atcmeetingabstracts.com/abstract/evolution-of-ccr4highcd4-subpopulations-in-renal-graft-blood-after-steroid-withdrawal-a-prospective-randomized-controlled-study-in-parallel-groups-preliminary-results/. Accessed November 22, 2024.« Back to 2017 American Transplant Congress